Literature DB >> 11866221

Gray-scale ultrasound in hepatic cirrhosis and chronic hepatitis: diagnosis, screening, and intervention.

Carlos Nicolau1, Luis Bianchi, Ramón Vilana.   

Abstract

Chronic hepatitis and hepatic cirrhosis are pathologies with high prevalence in the world population. Ultrasound (US) allows for a quick and precise examination of the liver parenchyma, the vascular structures, the biliary tract, and the abdominal cavity. Changes can be detected in the pattern of liver echostructure that suggest the presence of chronic liver disease, portal hypertension, and the presence of liver tumors. Moreover, US guidance provides an easy way for performing interventional procedures, such as biopsies for classifying the degree and type of liver disease, biopsies of focal liver lesions, and the application of percutaneous treatments for hepatocellular carcinoma (HCC). In this article we discuss the multiple applications of US in the management of patients with chronic liver disease.

Entities:  

Mesh:

Year:  2002        PMID: 11866221     DOI: 10.1016/s0887-2171(02)90026-0

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  9 in total

1.  Automated classification of liver disorders using ultrasound images.

Authors:  Fayyaz ul Amir Afsar Minhas; Durre Sabih; Mutawarra Hussain
Journal:  J Med Syst       Date:  2011-11-10       Impact factor: 4.460

Review 2.  Four-dimensional flow magnetic resonance imaging in cirrhosis.

Authors:  Zoran Stankovic
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  Approaches to the diagnosis of hepatocellular carcinoma.

Authors:  Morris Sherman
Journal:  Curr Gastroenterol Rep       Date:  2005-02

Review 4.  Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

Authors:  Moon Young Kim; Woo Kyoung Jeong; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 5.  Application of ultrasound for the diagnosis of cirrhosis/portal hypertension.

Authors:  Seul Ki Han; Moon Young Kim; Seong Hee Kang; Soon Koo Baik
Journal:  J Med Ultrason (2001)       Date:  2022-02-18       Impact factor: 1.878

6.  Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis.

Authors:  Lei Shen; Ji-Qiang Li; Min-De Zeng; Lun-Gen Lu; Si-Tao Fan; Han Bao
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

7.  Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.

Authors:  Hossein Ghanaati; Seyed Moayed Alavian; Ali Jafarian; Nasser Ebrahimi Daryani; Mohsen Nassiri-Toosi; Amir Hossein Jalali; Madjid Shakiba
Journal:  Iran J Radiol       Date:  2012-11-20       Impact factor: 0.212

8.  Liver cancer imaging: role of CT, MRI, US and PET.

Authors:  Maria Raquel Oliva; Sanjay Saini
Journal:  Cancer Imaging       Date:  2004-04-02       Impact factor: 3.909

9.  Transfer learning radiomics based on multimodal ultrasound imaging for staging liver fibrosis.

Authors:  Li-Yun Xue; Zhuo-Yun Jiang; Tian-Tian Fu; Qing-Min Wang; Yu-Li Zhu; Meng Dai; Wen-Ping Wang; Jin-Hua Yu; Hong Ding
Journal:  Eur Radiol       Date:  2020-01-21       Impact factor: 5.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.